Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract
Authors:
- 1 September 2005
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 22 (5) , 417-422
Abstract
Biliary secretion of antibiotic agents into the bile is considerably compromised by biliary obstruction, a precondition of bacterial cholangitis. Moxifloxacin may be advantageous according to secretion and antimicrobial spectrum.To establish the secretion of moxifloxacin into obstructed and non-obstructed bile.Biliary excretion of moxifloxacin was determined in plasma and bile of 10 patients with biliary obstruction and cholangitis and 10 patients without biliary obstruction 30 min after administration of 400 mg of moxifloxacin intravenously.The plasma concentration of moxifloxacin was similar in both groups (4.45 +/- 1.58 microg/mL; 4.33 +/- 1.23 microg/mL). The concentration of moxifloxacin in the bile was significantly lower in patients with biliary obstruction than without (4.63 +/- 3.94 microg/mL; range 0.71-14.40; vs. 16.90 +/- 13.77 microg/mL; range 1.79-42.50; P = 0.043). Although significantly different, the penetration index was extensively high in those without biliary obstruction (4.41 +/- 4.40; range 0.35-14.45) but still sufficient in those patients with obstructive cholangitis (1.02 +/- 0.74; range 0.29-2.83; P = 0.035).These findings are suggestive of an active secretion mechanism for moxifloxacin into the obstructed bile, producing a biliary concentration sufficiently above the minimal inhibitory concentrations for most of the expected bacteria.Keywords
This publication has 23 references indexed in Scilit:
- Comparative in vitro Activities of Three New Quinolones and Azithromycin against Aerobic Pathogens Causing Respiratory Tract and Abdominal Wound InfectionsChemotherapy, 2004
- In Vitro Activities of Moxifloxacin against 900 Aerobic and Anaerobic Surgical Isolates from Patients with Intra-Abdominal and Diabetic Foot InfectionsAntimicrobial Agents and Chemotherapy, 2004
- MoxifloxacinDrugs, 2004
- Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesisGastrointestinal Endoscopy, 2002
- Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: A prospective randomized trialGastrointestinal Endoscopy, 2002
- Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco‐2) cellsBritish Journal of Pharmacology, 2002
- Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainageZeitschrift für Gastroenterologie, 2000
- Clinical Significance of Magnetic Resonance Cholangiopancreatography (MRCP) Compared to Endoscopic Retrograde Cholangiopancreatography (ERCP)Endoscopy, 1997
- Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primatesHepatology, 1993
- Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum.Gut, 1976